K

KalVista Pharmaceuticals

D
KALV
USD
-0.23
(-2.0193%)
Market Closed
9,703.00
Volume
-3.4
EPS
-
Div Yield
-3.126050
P/E
482,284,667.52
Market Cap
Today
-2.0193%
1 Week
8.350%
1 Month
-1.151%
6 Months
-8.450%
12 Months
33.333%
Year To Date
-9.046%
All Time
0%

Title:
KalVista Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
Do you need help or have a question?